Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 916 results for "ranbaxy industries"

Ranbaxy Laboratories posts Rs185 crore loss in June quarter

Ranbaxy Laboratories Posts Loss of Rs 186 Crore in June Quarter

Mumbai: Ranbaxy Laboratories Ltd, which has agreed to be acquired by local rival Sun Pharmaceutical Industries Ltd, posted a net loss in the June quarter hit by a one-time provision. The Indian drug maker has been slapped with a slew of regulatory ... NDTV Profit, 11 hours ago

Ranbaxy's performance hinges on generic Diovan

Since Ranbaxy is being merged with Sun Pharmaceutical Industries, due by end 2014, an investment decision on the stock does not make sense. Photo: Pradeep Gaur/Mint Ranbaxy Laboratories Ltd posted a 50% increase in June quarter operating profit ...
 Livemint.com9 hours ago Ranbaxy provisions for settlement with US  Business Standard India5 hours ago Ranbaxy CEO sweetener a bitter pill for proxy firm  Financial Express5 days ago Avanir Settles With Ranbaxy Over Nuedexta Generic  FDA News4 weeks ago
India TV

Sun Pharma-Ranbaxy deal gets no-objection from BSE, NSE

The $4-billion merger of Ranbaxy Laboratories Ltd with Sun Pharmaceutical Industries Ltd has got clearance from the two leading stock exchanges — BSE and NSE. The no-objection from the two exchanges would allow the two companies to file their ...
 Hindu Business Line1 week ago Ranbaxy-Sun Pharma deal gets nod from BSE, NSE  Indian-Commodity1 week ago Sun Pharma-Ranbaxy merger gets BSE, NSE thumbs-up  Smart Investor1 week ago Sun Pharma-Ranbaxy Deal Gets 'No-Objection' From BSE, NSE  Silicon India1 week ago
Financial Express

BSE Sensex edges higher; defensive stocks Sun Pharma, Ranbaxy Laboratories surge

BSE Sensex rose on Friday as defensive stocks such as Sun Pharmaceutical Industries and Ranbaxy Laboratories jumped on the U.S. regulator's approval for a key drug while IT stocks gained after rival Accenture Plc reported robust quarterly revenue ...
 Financial Express1 month ago Sensex edges higher; Ranbaxy, Sun gain  Sify1 month ago Indian Shares Rise For Fifth Day  RTTNews.com1 week ago Sensex edges higher; defensive stocks surge  Sify1 month ago

Sun Pharma surges on getting nod from BSE, NSE for Ranbaxy deal

Sun Pharmaceutical Industries is currently trading at Rs. 752.60, up by 8.70 points or 1.17% from its previous closing of Rs. 743.90 on the BSE. The scrip opened at Rs. 751.00 and has touched a high and low of Rs. 757.50 and Rs. 745.75 ...
 Indian-Commodity1 week ago

Stocks in news: HDFC, HDFC Bank, Sun Pharma, MCX, Hindalco

Reliance Industries | HDFC | HDFC Bank | Sun Pharma | Ranbaxy Labs | Wockhardt | Coal India | Hindalco Industries | Kotak Mahindra Bank | MCX India | Financial Technologies | UltraTech Cement | SKF India | Clariant Chemicals | Motilal Oswal | Oberoi Realty ...
 Money Control1 week ago

Sun, Ranbaxy hire Mckinsey for merger assistance

Sun Pharmaceutical Industries, which is in the process of acquiring Ranbaxy Laboratories, has hired McKinsey & Company to facilitate the merger of the two leading drug makers in the domestic market, it is learnt. Sources said McKinsey had been given a clear mandate, including "integration, rationalisation and capacity utilisation".  Please click here for the Complete Coverage of Budget 2014 -15 Sun Pharma and Ranbaxy declined comment. A detailed e-mail questionnaire sent to McKinsey ...
 Rediff.com1 week ago McKinsey hired to assist merger of Sun, Ranbaxy  Smart Investor1 week ago

Ranbaxy shares jump on drug approval in US

Earlier in April, Sun Pharmaceuticals Industries announced acquisition of Ranbaxy in an all-share
 INooz1 month ago Ranbaxy shares jump over 5% on USFDA nod  Hindu Business Line1 month ago

RANBAXY LABORATORIES : Glenmark joins pharma companies setting up US plants

MUMBAI : With quality issues continuing to dog domestic pharma industry, more companies are de-risking their growth strategy by setting up manufacturing facilities in the US, the world's most lucrative market. The latest to jump on the bandwagon is ...
 4 Traders1 week ago Glenmark joins pharma companies setting up US plants  Times of India2 weeks ago India Pharma Pursues More Quality, Less Risk Offshore  Pharmaceutical Manufacturing Magazine2 weeks ago

Sun Pharma gets HC relief on $3.2-b Ranbaxy takeover

The Andhra Pradesh High Court on Saturday lifted a temporary stay it imposed on generic drugmaker Sun Pharmaceutical Industries Ltds $3.2 billion takeover of Ranbaxy Laboratories Ltd, a lawyer involved in the case said, paving the way for both companies to ...
 Deccan Herald2 months ago HC lifts stay on Sun Pharma's $3.2 billion Ranbaxy takeover  Rediff.com2 months ago BIZ BRIEFS  Himalayan times2 months ago Stay on Sun-Ranbaxy merger lifted  The Hindu2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less